KREHER NERISSA
SEC insider (Form 3/4/5 filer). CIK 0001741850. Director at Xeris Biopharma Holdings, Inc. (XERS) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in CHICAGO, IL.
Companies KREHER NERISSA has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Director
- Rezolute, Inc. (RZLT): Director
KREHER NERISSA
CIK: 0001741850
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 1, 2026XERS
Xeris Biopharma Holdings, Inc.
AwardDirect33.6K shares- - Nov 19, 2025RZLT
Rezolute, Inc.
AwardDirect21K shares- - Jun 13, 2025RZLT
Rezolute, Inc.
PurchaseDirect3.1K shares at avg. $3.25$10K - Jun 10, 2025RZLT
Rezolute, Inc.
AwardDirect9K shares- - Feb 16, 2025RZLT
Rezolute, Inc.
AwardDirect25.5K shares-
1-5 of 5 transactions